Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 672-42-4 | MDL No. : | MFCD08436606 |
Formula : | C5H4F3N3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | XJHPDOAHPIXTPH-UHFFFAOYSA-N |
M.W : | 163.10 | Pubchem ID : | 244056 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.2 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 31.44 |
TPSA : | 51.8 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.75 cm/s |
Log Po/w (iLOGP) : | 1.14 |
Log Po/w (XLOGP3) : | 0.77 |
Log Po/w (WLOGP) : | 2.24 |
Log Po/w (MLOGP) : | 0.51 |
Log Po/w (SILICOS-IT) : | 1.25 |
Consensus Log Po/w : | 1.18 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.67 |
Solubility : | 3.46 mg/ml ; 0.0212 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.44 |
Solubility : | 5.95 mg/ml ; 0.0365 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.17 |
Solubility : | 1.1 mg/ml ; 0.00676 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.52 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338-P310 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 672-46-8 ]
2-(Trifluoromethyl)pyrimidine-4,6-diamine
Similarity: 0.87
[ 1378259-23-4 ]
6-Bromo-2-(trifluoromethyl)pyrimidin-4-amine
Similarity: 0.81
[ 1017464-05-9 ]
4-Methyl-2-(trifluoromethyl)pyrimidine
Similarity: 0.80
[ 73418-87-8 ]
2-(Trifluoromethyl)pyrimidin-5-amine
Similarity: 0.78
[ 672-46-8 ]
2-(Trifluoromethyl)pyrimidine-4,6-diamine
Similarity: 0.87
[ 1378259-23-4 ]
6-Bromo-2-(trifluoromethyl)pyrimidin-4-amine
Similarity: 0.81
[ 73418-87-8 ]
2-(Trifluoromethyl)pyrimidin-5-amine
Similarity: 0.78
[ 1416372-67-2 ]
5-Fluoro-2-methylpyrimidin-4-amine
Similarity: 0.76
[ 672-46-8 ]
2-(Trifluoromethyl)pyrimidine-4,6-diamine
Similarity: 0.87
[ 1378259-23-4 ]
6-Bromo-2-(trifluoromethyl)pyrimidin-4-amine
Similarity: 0.81
[ 1017464-05-9 ]
4-Methyl-2-(trifluoromethyl)pyrimidine
Similarity: 0.80
[ 73418-87-8 ]
2-(Trifluoromethyl)pyrimidin-5-amine
Similarity: 0.78
[ 672-46-8 ]
2-(Trifluoromethyl)pyrimidine-4,6-diamine
Similarity: 0.87
[ 1378259-23-4 ]
6-Bromo-2-(trifluoromethyl)pyrimidin-4-amine
Similarity: 0.81
[ 1017464-05-9 ]
4-Methyl-2-(trifluoromethyl)pyrimidine
Similarity: 0.80
[ 73418-87-8 ]
2-(Trifluoromethyl)pyrimidin-5-amine
Similarity: 0.78